MaxCyte, Inc.
MXCT
$2.04
-$0.02-0.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 37.68M | 38.63M | 45.60M | 45.44M | 44.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.68M | 38.63M | 45.60M | 45.44M | 44.05M |
| Cost of Revenue | 7.19M | 7.10M | 6.39M | 5.26M | 5.15M |
| Gross Profit | 30.48M | 31.53M | 39.21M | 40.18M | 38.91M |
| SG&A Expenses | 56.11M | 56.36M | 57.96M | 57.87M | 57.72M |
| Depreciation & Amortization | 4.14M | 4.14M | 4.19M | 4.20M | 4.14M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 88.89M | 89.83M | 91.99M | 91.73M | 91.45M |
| Operating Income | -51.22M | -51.20M | -46.39M | -46.29M | -47.40M |
| Income Before Tax | -41.79M | -41.06M | -35.74M | -35.43M | -36.57M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.79 | -41.06 | -35.74 | -35.43 | -36.57 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -41.79M | -41.06M | -35.74M | -35.43M | -36.57M |
| EBIT | -51.22M | -51.20M | -46.39M | -46.29M | -47.40M |
| EBITDA | -46.92M | -46.88M | -42.03M | -41.92M | -43.08M |
| EPS Basic | -0.40 | -0.39 | -0.34 | -0.34 | -0.35 |
| Normalized Basic EPS | -0.25 | -0.24 | -0.21 | -0.21 | -0.22 |
| EPS Diluted | -0.40 | -0.39 | -0.34 | -0.34 | -0.35 |
| Normalized Diluted EPS | -0.25 | -0.24 | -0.21 | -0.21 | -0.22 |
| Average Basic Shares Outstanding | 421.25M | 419.39M | 417.54M | 415.88M | 414.31M |
| Average Diluted Shares Outstanding | 421.25M | 419.39M | 417.54M | 415.88M | 414.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |